Your own cells could stop Cancer's return: major trial tests personalized vaccine
NCT ID NCT02448173
Summary
This study is testing a personalized vaccine called OncoVax to prevent colon cancer from coming back after surgery. The vaccine is made from a patient's own cancer cells and is designed to train the immune system to attack any remaining cancer. The trial will enroll 550 patients who have had surgery for Stage II colon cancer to see if the vaccine improves survival and prevents recurrence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE II COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Halifax Health Medical Center
Port Orange, Florida, 32127, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.